AAP
EVH icon

Arax Advisory Partners’s Evolent Health EVH Stock Holding History

Arax Advisory Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180 Buy
+6
New +$19 ﹤0.01% 3559
2025
Q4 		– Sell
-479
Closed -$4.05K – 4226
2025
Q3 		$4.05K Buy
+479
New +$4.65K ﹤0.01% 2927

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arax Advisory Partners's EVH Position: Q1 2026 in Review

Arax Advisory Partners opened a new position in Evolent Health (EVH) in Q1 2026: 6 shares worth $180. The stake represents ﹤0.01% of the portfolio and ranks #3559 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in EVH as recently as Q3 2025.

Arax Advisory Partners first reported a position in EVH in Q3 2025 and has held it in 2 quarters since. The position peaked at $4.05K in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Arax Advisory Partners held 6 shares of Evolent Health worth $180 as of Q1 2026.
  • Evolent Health was a new Arax Advisory Partners position in Q1 2026.
  • Evolent Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3559 holding.
  • Arax Advisory Partners first reported a position in Evolent Health in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Evolent Health position peaked at $4.05K in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.